With coronavirus tests in short supply around the country, the revolutionary gene-editing tool CRISPR could help, and a Cambridge, Mass. company is trying to develop quick, cheap, accurate tests that could help with reopening.
↧
With coronavirus tests in short supply around the country, the revolutionary gene-editing tool CRISPR could help, and a Cambridge, Mass. company is trying to develop quick, cheap, accurate tests that could help with reopening.